AU Patent

AU2023287202A1 — Methods and uses of boron compounds in the treatment of nontuberculous mycobacterium infections and pharmaceutical compositions for treatment of same

Assigned to Shanghai Micurx Pharmaceutical Co Ltd · Expires 2024-06-06 · 2y expired

What this patent protects

Provided herein are organoboron compounds of Formula I, or salts thereof, and pharmaceutical compositions and the use of organoboron compounds and pharmaceutical compositions for the treatment of nontuberculous mycobacterium infections.

USPTO Abstract

Provided herein are organoboron compounds of Formula I, or salts thereof, and pharmaceutical compositions and the use of organoboron compounds and pharmaceutical compositions for the treatment of nontuberculous mycobacterium infections.

Drugs covered by this patent

Patent Metadata

Patent number
AU2023287202A1
Jurisdiction
AU
Classification
—
Expires
2024-06-06
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Micurx Pharmaceutical Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.